接种COVID-19疫苗后的心肌炎:我们学到了什么?
Joseph Abourjeili1, Christelle Lattouf1, Anthony Abou Mrad1
1American University of Beirut Medical Center, Beirut, Lebanon.
Sage open pediatrics..
|July 4, 2025
概括
接种mRNACOVID-19疫苗后的心肌炎很少见,主要影响第二剂疫苗接种几天内的年轻男性. 大多数病例是轻微的,并随着治疗而消失,证实了疫苗的安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,需要快速开发疫苗.
- mRNA COVID-19 疫苗对于全球控制至关重要.
- 人们对潜在的心血管不良事件,特别是心肌炎存在担忧.
研究的目的:
- 审查和分析mRNACOVID-19疫苗接种后心肌炎的发病率和特征.
- 评估mRNA COVID-19疫苗对心肌炎的风险益处概况.
主要方法:
- 对40多项研究进行了系统审查和分析.
- 检查已报告的mRNACOVID-19疫苗接种后心肌炎病例.
- 本次审查没有进行任何临床试验.
主要成果:
- 肌心炎发病率在第二剂mRNA COVID-19疫苗接种后的2-4天内最高.
- 受影响的个体主要是12-39岁的男性.
- 像胸痛和呼吸障碍这样的症状通常是轻微的,并且对支持性护理有反应.
结论:
- 在mRNA COVID-19疫苗接种后心肌炎的风险很低.
- 提出的机制包括分子模仿和过敏.
- 接种COVID-19疫苗的好处明显超过了风险.
相关概念视频
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Myocarditis II: Clinical Features and Diagnostic Tests
31
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
31
Myocarditis I: Introduction
35
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
Myocarditis IV: Nursing Management
36
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
36
Pericarditis I: Introduction
26
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
26
Pericarditis III: Medical Management
28
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
28


